Abstract:AIM:To clone hpaA gene from a clinical strain of Helicobacter pylori and to construct the expression vector of the gene and to identify immunity of the fusion protein. METHODS:The hpaA gene from a clinical isolate Y06 of H. pylori was amplified by high fidelity PCR.The nucleotide sequence of the target DNA amplification fragment was sequenced after T-A cloning.The recombinant expression vector inserted with hpaA gene was constructed.The expression of HpaA fusion protein in E.coli BL21DE3 induced by IPTG at different dosages was examined by SDS-PAGE.Western blot with commercial antibody against whole cell of H.pylori as well as immunodiffusion assay with selfprepared rabbit antiserum against HpaA fusion protein were applied to determine immunity of the fusion protein.ELISA was used to detect the antibody against HpaA in sera of 125 patients infected with H.pylori and to examine HpaA expression of 109 clinical isolates of H.pylori. RESULTS:In comparison with the reported corresponding sequences, the homologies of nucleotide and putative amino acid sequences of the cloned hpaA gene were from 94.25-97.32% and 95.38-98.46%, respectively.The output of HpaA fusion protein in its expression system of pET32a-hpaA-BL21DE3 was approximately 40 % of the total bacterial proteins.HpaA fusion protein was able to combine with the commercial antibody against whole cell of H.pylori and to induce rabbit producing specific antiserum with 1:4 immunodiffusion titer after the animal was immunized with the fusion protein.81.6 % of the serum samples from 125 patients infected with H.pylori (102/125) were positive for HpaA antibody and all of the tested isolates of H.pylori (109/ 109) were detectable for HpaA.CONCLUSION: A prokaryotic expression system with high efficiency of H.pylori hpaA gene was successfully established.The HpaA expressing fusion protein showed satisfactory immunoreactivity and antigenicity.High frequencies of HpaA expression in different H.pylori clinical strains and specific antibody production in H.pylori infected patients indicate that HpaA is an excellent and ideal antigen for developing H.pylori vaccine.

Prokaryotic Expression and Polyclonal Antibody Preparation of HPV6b E7 Protein

[Expression and Polyclonal Antibody Preparation of HPV-11E7 Protein].

Cloning and Expression of HPV 6b E7 Gene

Expression and Purification of HPV58 E1 Protein and Preparation of Polyclonal Antibodies against HPV 58 E1 Protein

Preparation of a Monoclonal Antibody Against the Human Papillomavirus Type 16 E7 (HPV 16 E7 ) Protein

Construction of Eukaryotic Expression Fusion Plasmid of HPV6b E7 Gene and CRT Gene

Identification of predicted epitopes of HLA-A * 0201-restricted cytotoxic T lymphocytes derived from human papillomavirus type 11 E7 antigen

Production of Polyclonal Antibody to the HPV58 E7 Protein and Its Detection in Cervical Cancer.

[Cloning of Human Papillomavirus Type 16 E7 Gene and Expression in E. Coli].

Construction, Expression, Purification and Identification of Chimeric HPV16 E7-L1 Virus Like Particles

Expression and Purification of HPV58 E1^E4 Fusion Protein and Preparation of Polyclonal Antibody Against HPV58 E1^E4

[Cloning and Expressing of Human Papillomavirus 16 E7C Subgene].

The construction of prokaryotic expr ession product of HPV6b L1-TpN15 fusion gene

Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies

Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions.

Construction of Recombinant HPV16 E7 Antigen Vaccinia Virus

Production of recombinant HPV11/16 E6/E7-MBP-His6 fusion proteins and their potential to induce cytokine secretion by immune cells in peripheral blood

Development of Polyclonal Antibody Against E1 Protein of HPV and Application in Detection of Cervic Lesions

Construction of Hpaa Gene from A Clinical Isolate of Helicobacter Pylori and Identification of Fusion Protein

Egg yolk antibodies against the E7 oncogenic protein of human papillomavirus type 16

Screening and identification of B cell epitope within the major capsid protein L1 of HPV 52, using monoclonal antibodies